Page 23 - AN-3-1
P. 23
Advanced Neurology PSD-95 in neurodevelopmental disorders
of synaptic protein is associated with the antidepressant- stress disorder. Neurobiol Stress. 2015;1:89-99.
like effects of ferulic acid in a chronic model of depression. doi: 10.1016/j.ynstr.2014.10.002
Physiol Behav. 2017;169:184-188.
108. Johnson JW, Kotermanski SE. Mechanism of action of
doi: 10.1016/j.physbeh.2016.12.003
memantine. Curr Pharmacol. 2006;6(1):61-67.
98. Li Q, Gao Y, Li H, et al. Brain structure and synaptic doi: 10.1016/j.coph.2005.09.007
related protein expression alterations after antidepressant
treatment in WKY depression model rats. J Affect Disord. 109. Krivoy A, Weizman A, Laor L, Hellinger N, Zemishlany Z,
2022;314:293-302. Fischel T. Addition of memantine to antipsychotic treatment
in schizophrenia inpatients with residual symptoms:
doi: 10.1016/j.jad.2022.07.037 A preliminary study. Eur Neuropsychopharmacol.
99. Nguyen V, Tiemann D, Park E, Salehi A. Alpha-2 agonists. 2008;18(2):117-121.
Anesth Clin. 2017;35(2):233-245. doi: 10.1016/j.euroneuro.2007.07.008
doi: 10.1016/j.anclin.2017.01.009 110. Olney JW, Farber NB. Glutamate receptor dysfunction and
100. Giovannitti JA Jr., Thoms SM, Crawford JJ. Alpha-2 schizophrenia. Arch Gen Psychiatry. 1995;52(12):998-1007.
adrenergic receptor agonists: A review of current clinical doi: 10.1001/archpsyc.1995.03950240016004
applications. Anesth Prog. 2015;62(1):31-39.
111. Carpenter SS, Hatchett AD, Fuller MA. Catatonic
doi: 10.2344/0003-3006-62.1.31 schizophrenia and the use of memantine. Ann
101. Munawar N, Al Madhoun A, Nader J, et al. 24-LB: Pharmacother. 2006;40(2):344-346.
Guanfacine normalizes Presynaptic alpha-2 adrenoceptors doi: 10.1345/aph.1G297
enrichment and ameliorates neuropathic pain in type 1
diabetic rats. Diabetes. 2022;71(Suppl 1):2146. 112. Prickaerts J, Gieling ET, Bruder AK, van der Staay FJ,
Vanmierlo T. Long‐term effects of prenatal allopurinol
doi: 10.3390/pharmaceutics14102146 treatment on brain plasticity markers in low and normal
102. Wang M, Ramos BP, Paspalas CD, et al. α2A-adrenoceptors birth weight piglets. Int J Dev Neurosci. 2014;33(1):29-32.
strengthen working memory networks by inhibiting doi: 10.1016/j.ijdevneu.2013.11.001
cAMP-HCN channel signaling in prefrontal cortex. Cell.
2007;129(2):397-410. 113. Herken H, Gurel A, Selek S, et al. Adenosine deaminase,
nitric oxide, superoxide dismutase, and xanthine oxidase
doi: 10.1016/j.cell.2007.03.015 in patients with major depression: Impact of antidepressant
103. Smith RJ, Aston-Jones G. α2 Adrenergic and imidazoline treatment. Arch Med Res. 2007;38(2):247-252.
receptor agonists prevent cue-induced cocaine seeking. Biol doi: 10.1016/j.arcmed.2006.10.005
Psychiatry. 2011;70(8):712-719.
114. Gibney SM, Fagan EM, Waldron AM, O’Byrne J,
doi: 10.1016/j.biopsych.2011.06.010 Connor TJ, Harkin A. Inhibition of stress-induced hepatic
104. Sabetkasaie M, Vala S, Khansefid N, Hosseini AR, Sadat tryptophan 2, 3-dioxygenase exhibits antidepressant
Ladgevardi MAR. Clonidine and guanfacine-induced activity in an animal model of depressive behaviour. Int J
antinociception in visceral pain: Possible role of α2/I2 Neuropsychopharmacol. 2014;17(6):917-928.
binding sites. Eur Pharmacol. 2004;501(1):95-101. doi: 10.1017/S1461145713001673
doi: 10.1016/j.ejphar.2004.08.010 115. Réus GZ, Jansen K, Titus S, Carvalho AF, Gabbay V, Quevedo J.
105. Birnbaum SG, Podell DM, Arnsten AFT. Noradrenergic Kynurenine pathway dysfunction in the pathophysiology
alpha-2 receptor agonists reverse working memory deficits and treatment of depression: Evidences from animal and
induced by the anxiogenic drug, FG7142, in rats. Pharmacol human studies. J Psychiatr Res. 2015;68:316-328.
Biochem Behav. 2000;67(3):397-403. doi: 10.1016/j.jpsychires.2015.05.007
doi: 10.1016/s0091-3057(00)00306-3 116. Yoshii A, Constantine-Paton M. BDNF induces
106. Hains AB, Yabe Y, Arnsten AF. Chronic stimulation of transport of PSD-95 to dendrites through PI3K-AKT
alpha-2A-adrenoceptors with guanfacine protects rodent signaling after NMDA receptor activation. Nat Neurosci.
prefrontal cortex dendritic spines and cognition from the 2007;10(6):702-711.
effects of chronic stress. Neurobiol Stress. 2015;2:1-9. doi: 10.1038/nn1903
doi: 10.1016/j.ynstr.2015.01.001 117. Fond G, Loundou A, Rabu C, et al. Ketamine administration
in depressive disorders: A systematic review and meta-
107. Arnsten AFT, Raskind MA, Taylor FB, Connor DF. The
effects of stress exposure on prefrontal cortex: Translating analysis. Psychopharmacology (Berl). 2014;231:3663-3676.
basic research into successful treatments for post-traumatic doi: 10.1007/s00213-014-3664-5
Volume 3 Issue 1 (2024) 17 https://doi.org/10.36922/an.2095

